Grand Pharmaceutical Group Dividend
Dividend criteria checks 2/6
Grand Pharmaceutical Group is a dividend paying company with a current yield of 5.73% that is well covered by earnings. Next payment date is on 27th June, 2024 with an ex-dividend date of 6th June, 2024.
Key information
5.7%
Dividend yield
49%
Payout ratio
| Industry average yield | 3.4% |
| Next dividend pay date | 27 Jun 24 |
| Ex dividend date | 06 Jun 24 |
| Dividend per share | n/a |
| Earnings per share | HK$0.54 |
| Dividend yield forecast in 3Y | 3.5% |
Recent dividend updates
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Apr 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14
Jun 04Recent updates
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Apr 25Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Sep 26Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14
Jun 04Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?
Sep 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Jul 28Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11
May 29Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?
Apr 08Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late
Jan 24These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price
Nov 27With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting
Oct 25China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly
Sep 01Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?
Jul 12We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt
Apr 26Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)
Apr 08Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching
Mar 24If You Had Bought China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Shares Five Years Ago You'd Have Earned 332% Returns
Mar 11Are Robust Financials Driving The Recent Rally In China Grand Pharmaceutical and Healthcare Holdings Limited's (HKG:512) Stock?
Feb 22China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Are Growing But Is There More To The Story?
Jan 21Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 512 has been paying a dividend for less than 10 years.
Growing Dividend: 512's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Grand Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (512) | 5.7% |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 7.8% |
| Industry Average (Pharmaceuticals) | 3.4% |
| Analyst forecast in 3 Years (512) | 3.5% |
Notable Dividend: 512's dividend (5.73%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.17%).
High Dividend: 512's dividend (5.73%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.95%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (48.5%), 512's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate 512's cash payout ratio to determine if its dividend payments are covered by cash flows.